Nasdaq Copenhagen A/S: Veloxis Pharmaceuticals A/S - admittance to trading and official listing of new shares due to exercise of employee warrants

The share capital of Veloxis Pharmaceuticals has been increased. The admittance
to trading and official listing of new shares will take effect on 11 December
2018 in the ISIN below. 



ISIN:                  DK0060048148                             
----------------------------------------------------------------
Name:                  Veloxis Pharmaceuticals                  
----------------------------------------------------------------
Volume before change:  1,712,838,531 shares (DKK 171,283,853.10)
----------------------------------------------------------------
Change:                4,948,055 shares (DKK 494,805.50)        
----------------------------------------------------------------
Volume after change:   1,717,786,586 shares (DKK 171,778,658.60)
----------------------------------------------------------------
Subscription price:    DKK 0.35 - 423,400 shares                
                       DKK 0.94 - 8,315 shares                  
                       DKK 0.95 - 1,576,310 shares              
                       DKK 1.01 - 2,940,030 shares              
----------------------------------------------------------------
Denomination:          DKK 0.10                                 
----------------------------------------------------------------
Short name:            VELO                                     
----------------------------------------------------------------
Orderbook ID:          36992                                    
----------------------------------------------------------------



For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33
93 34 60

Attachment:
https://cns.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=702501